Clinical trials
Phase 2/3 trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 14 |
| 2021 | 11 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 15 |
| Active, not recruiting | 10 |
| Terminated | 10 |
| Unknown status | 5 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| Bristol-Myers Squibb | 6 |
| Pfizer | 6 |
| Washington University School of Medicine | 4 |
| EyeBiotech Ltd. | 3 |
| AbbVie | 2 |
| Bayer | 2 |
| Clover Biopharmaceuticals AUS Pty | 2 |
| Fundación Santa Fe de Bogota | 2 |
| Janssen Research & Development, LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 19 |
| Alzheimer Disease | 5 |
| Coronavirus Infections | 5 |
| Dementia | 5 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colitis, Ulcerative | 2 |
| Crohn Disease | 2 |
| Hemophilia A | 2 |
| Lung Neoplasms | 2 |
| Venous Thromboembolism | 2 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.